1. Home
  2. GNFT vs MRCC Comparison

GNFT vs MRCC Comparison

Compare GNFT & MRCC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GNFT
  • MRCC
  • Stock Information
  • Founded
  • GNFT 1999
  • MRCC 2011
  • Country
  • GNFT France
  • MRCC United States
  • Employees
  • GNFT N/A
  • MRCC N/A
  • Industry
  • GNFT Biotechnology: Biological Products (No Diagnostic Substances)
  • MRCC Investment Managers
  • Sector
  • GNFT Health Care
  • MRCC Finance
  • Exchange
  • GNFT Nasdaq
  • MRCC Nasdaq
  • Market Cap
  • GNFT 186.3M
  • MRCC 176.4M
  • IPO Year
  • GNFT 2019
  • MRCC 2012
  • Fundamental
  • Price
  • GNFT $3.75
  • MRCC $6.42
  • Analyst Decision
  • GNFT Strong Buy
  • MRCC Hold
  • Analyst Count
  • GNFT 1
  • MRCC 1
  • Target Price
  • GNFT $13.00
  • MRCC $8.00
  • AVG Volume (30 Days)
  • GNFT 3.8K
  • MRCC 84.7K
  • Earning Date
  • GNFT 04-24-2025
  • MRCC 08-06-2025
  • Dividend Yield
  • GNFT N/A
  • MRCC 15.67%
  • EPS Growth
  • GNFT N/A
  • MRCC 3301.50
  • EPS
  • GNFT 0.03
  • MRCC 0.32
  • Revenue
  • GNFT $73,187,701.00
  • MRCC $56,983,000.00
  • Revenue This Year
  • GNFT $15.98
  • MRCC N/A
  • Revenue Next Year
  • GNFT N/A
  • MRCC N/A
  • P/E Ratio
  • GNFT $120.71
  • MRCC $19.63
  • Revenue Growth
  • GNFT 105.01
  • MRCC N/A
  • 52 Week Low
  • GNFT $2.55
  • MRCC $6.11
  • 52 Week High
  • GNFT $6.42
  • MRCC $8.85
  • Technical
  • Relative Strength Index (RSI)
  • GNFT 44.52
  • MRCC 49.55
  • Support Level
  • GNFT $3.44
  • MRCC $6.32
  • Resistance Level
  • GNFT $3.81
  • MRCC $6.50
  • Average True Range (ATR)
  • GNFT 0.17
  • MRCC 0.16
  • MACD
  • GNFT -0.00
  • MRCC 0.02
  • Stochastic Oscillator
  • GNFT 56.65
  • MRCC 52.08

About GNFT GENFIT S.A.

Genfit SA is a biotechnology company focused on metabolic and inflammatory diseases, with a particular focus on the liver and gastroenterology. The company's research and development activity relies on its expertise in modulating gene expression through nuclear receptors. Genfit utilizes acquisitions, strategic alliances, and licensing agreements in order to fund the further development of its products. It has one segment the research and development of medicines and diagnostic solutions, the marketing of which depends on the success of the clinical development phase.

About MRCC Monroe Capital Corporation

Monroe Capital Corp is a speciality finance company focused on providing financing to lower middle-market companies, in the U.S. and Canada. The company provides customized financing solutions focused on senior, unitranche, and junior secured debt and unsecured subordinated debt and equity, including equity co-investments in preferred and common stock and warrants.

Share on Social Networks: